JPS6437293A - Eucayotic developing vector having enhancer subelement mass body, its production and development of protein in mammal - Google Patents

Eucayotic developing vector having enhancer subelement mass body, its production and development of protein in mammal

Info

Publication number
JPS6437293A
JPS6437293A JP63167020A JP16702088A JPS6437293A JP S6437293 A JPS6437293 A JP S6437293A JP 63167020 A JP63167020 A JP 63167020A JP 16702088 A JP16702088 A JP 16702088A JP S6437293 A JPS6437293 A JP S6437293A
Authority
JP
Japan
Prior art keywords
enhancer
subelement
eucayotic
mammal
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63167020A
Other languages
English (en)
Inventor
Shiyafunaa Buarutaa
Gunaaru Buesuchin Nirusu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of JPS6437293A publication Critical patent/JPS6437293A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795Porphyrin- or corrin-ring-containing peptides
    • C07K14/805Haemoglobins; Myoglobins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP63167020A 1987-07-11 1988-07-06 Eucayotic developing vector having enhancer subelement mass body, its production and development of protein in mammal Pending JPS6437293A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873723075 DE3723075A1 (de) 1987-07-11 1987-07-11 Eukaryotische expressionsvektoren mit multimeren enhancer-subelementen, verfahren zu ihrer herstellung und verwendung

Publications (1)

Publication Number Publication Date
JPS6437293A true JPS6437293A (en) 1989-02-07

Family

ID=6331452

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63167020A Pending JPS6437293A (en) 1987-07-11 1988-07-06 Eucayotic developing vector having enhancer subelement mass body, its production and development of protein in mammal

Country Status (5)

Country Link
US (1) US4983518A (ja)
EP (1) EP0299303B1 (ja)
JP (1) JPS6437293A (ja)
AT (1) ATE86303T1 (ja)
DE (2) DE3723075A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008682A1 (en) * 1991-11-05 1993-05-13 State University Of New Jersey - Rutgers A method of obtaining high methionine-containing corn seeds, and uses thereof
US5512483A (en) * 1993-05-21 1996-04-30 Mcgill University Expression vectors responsive to steroid hormones
FR2730735B1 (fr) * 1995-02-20 1997-05-09 Pasteur Institut Sequences amplificatrices, vecteurs portant ces sequences et leurs utilisations dans des compositions pour l'expression de sequences nucleotidiques dans des cellules transfectees, applications therapeutiques et vaccinales
CZ20022372A3 (cs) * 1999-12-13 2002-11-13 Bioniche Life Sciences Inc. Terapeuticky pouľitelné syntetické oligonukleotidy
US20020091095A1 (en) * 1999-12-13 2002-07-11 Phillips Nigel C. Modulation of Fas and FasL expression
US7585962B2 (en) 2001-10-19 2009-09-08 The Mclean Hospital Corporation Multimerized enhancer domains for cell-specific expression

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4404785A (en) * 1984-05-25 1985-12-31 Dana-Farber Cancer Institute, Inc. Ltr vectors, methods of preparation and use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PROC.NATL.ACAD.SCI.U.S.A=1985 *

Also Published As

Publication number Publication date
EP0299303B1 (de) 1993-03-03
DE3878760D1 (de) 1993-04-08
EP0299303A3 (en) 1989-11-29
DE3723075A1 (de) 1989-01-19
US4983518A (en) 1991-01-08
EP0299303A2 (de) 1989-01-18
ATE86303T1 (de) 1993-03-15

Similar Documents

Publication Publication Date Title
EP0244234A3 (en) Transformation of trichoderma
DE2966390D1 (en) A dna transfer vector, a microorganism modified by said vector and the synthesis of a eucaryotic protein by the modified microorganism
GB2137208B (en) The use of the gal1 promoter
NZ227177A (en) Vectors and dna compounds for the expression of human protein c
AU588220B2 (en) Improved expression vector and use thereof
IL90129A0 (en) Recombinant dna expression vectors and dna compounds that encode deacetoxycephalosporin c synthetase
EP0282070A3 (en) Vector access to memories
EP0324647A3 (en) Vector for the expression of fusion proteins and protein immunogens
BR9407104A (pt) Processo para a preparação e recuperação de ácido 7-amino desacetoxi cefalosporânico (7-adca) vetor de ADN recombinante e célula hospedeira transformada com um vetor definido
BG50281A3 (bg) Метод за получаване на рекомбинантн днк експресионен вектор
JPS6437293A (en) Eucayotic developing vector having enhancer subelement mass body, its production and development of protein in mammal
EP0462836A3 (en) Recombinant vector plasmid capable of expressing human manganese superoxide dismutase, and process of producing this enzyme
NZ221524A (en) Enzymatic built aqueous liquid detergent with protein stabiliser
DE2966118D1 (en) Process for modifying starch and pregelatinized modified starch for use in instant puddings
EP0363436A4 (en) CLONED GENES OF PROTEIN G VERSIONS AND PROTEIN G VERSIONS EXPRESSED THEREOF.
JPS5550892A (en) Protein production * modified dna and vector applicable to said method
EP0295859A3 (en) Production of proteins in active forms
MTP857B (en) Purified protein and process therefor
GR3020786T3 (en) Recombinant DNA expression vectors and DNA compounds that encode isopenicillin N epimerase activity
FI892761A7 (fi) Ekspressiovektoreita fuusioitumattomien proteiinien valmistamiseksi mikro-organismeissa
ZA823820B (en) Hybrid vector and process for improving the amplification and expression of hybrid vectors by the use of mitochondrial dna
GB2133797B (en) Dna expression vectors useful in bacillus cells
JPS6416850A (en) Stabilizer and auxiliary stabilizer for plastic
HUT40162A (en) Recombinant dna expression vectors and process for gene expression
DK434588D0 (da) Promotor samt vektor indeholdende promotoren